US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 0.2420
  • -0.0219-8.30%
Close May 3 16:00 ET
  • 0.2404
  • -0.0016-0.66%
Post 17:04 ET
1.47MMarket Cap-576P/E (TTM)

InMed Pharmaceuticals Key Stats

InMed Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

1.24M

+163.99%
EPS(YoY)

-0.19

+79.12%

No Data

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.407M--
--2024/Q3-- / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
--2022/Q3403.100K / 765.490K--
Feb 15, 20222022/Q2337.690K / 157.920K--
--2022/Q10.000 / 317.240K--
Sep 24, 20212021/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.407M--
--2024/Q3-- / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
--2022/Q3403.100K / 765.490K--
Feb 15, 20222022/Q2337.690K / 157.920K--
--2022/Q10.000 / 317.240K--
Sep 24, 20212021/Q40.000 / 0.000--

Unlock Free Earnings Estimates

InMed Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg